While investors shifted their focus from growth stocks to value stocks earlier this year to capitalize on the economic recovery, many growth stocks have been rebounding lately as investors now bet on the economy’s solid growth prospects. Against this backdrop, we think investing in undervalued growth stocks, such as Regeneron Pharmaceuticals (REGN), Energy Transfer (ET), and POSCO (PKX), should allow investors to maximize returns in the near term. Read on.